IGC Pharma Inc (IGC)
0.4761
-0.11
(-18.82%)
USD |
NYAM |
Apr 18, 16:00
0.4991
+0.02
(+4.83%)
After-Hours: 20:00
IGC Pharma Cash from Investing (TTM): -0.236M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.236M |
| September 30, 2023 | -0.192M |
| June 30, 2023 | -0.082M |
| March 31, 2023 | -0.235M |
| December 31, 2022 | -0.546M |
| September 30, 2022 | -0.578M |
| June 30, 2022 | -0.805M |
| March 31, 2022 | -0.742M |
| December 31, 2021 | 1.739M |
| September 30, 2021 | 3.442M |
| June 30, 2021 | 4.428M |
| March 31, 2021 | 3.387M |
| December 31, 2020 | 0.718M |
| September 30, 2020 | -2.631M |
| June 30, 2020 | -4.497M |
| March 31, 2020 | -9.547M |
| December 31, 2019 | -9.017M |
| September 30, 2019 | -7.355M |
| June 30, 2019 | -6.438M |
| March 31, 2019 | -0.26M |
| December 31, 2018 | -0.405M |
| September 30, 2018 | -0.525M |
| June 30, 2018 | -0.6611M |
| March 31, 2018 | -0.657M |
| December 31, 2017 | -0.2717M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.234M |
| June 30, 2017 | -0.1274M |
| March 31, 2017 | -0.2414M |
| December 31, 2016 | -0.4891M |
| September 30, 2016 | -0.3854M |
| June 30, 2016 | -0.2748M |
| March 31, 2016 | -0.1834M |
| December 31, 2015 | 0.2338M |
| September 30, 2015 | 0.2326M |
| June 30, 2015 | -0.4197M |
| March 31, 2015 | -0.5181M |
| December 31, 2014 | -0.7138M |
| September 30, 2014 | -0.701M |
| June 30, 2014 | -0.1217M |
| March 31, 2014 | 0.0031M |
| December 31, 2013 | -0.4477M |
| September 30, 2013 | -0.3872M |
| June 30, 2013 | -0.3232M |
| March 31, 2013 | -0.0747M |
| December 31, 2012 | 0.812M |
| September 30, 2012 | 4.943M |
| June 30, 2012 | 4.897M |
| March 31, 2012 | 4.669M |
| December 31, 2011 | 4.176M |
| September 30, 2011 | -0.1728M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-9.547M
Minimum
Mar 2020
4.428M
Maximum
Jun 2021
-1.536M
Average
-0.546M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| CEL-SCI Corp | -0.3835M |
| AIM ImmunoTech Inc | -0.832M |
| NovaBay Pharmaceuticals Inc | -0.019M |
| Protalix BioTherapeutics Inc | -16.71M |
| Palatin Technologies Inc | 9.293M |